Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulf Tiemann

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
STAR Protocols|May 22, 2025
Protocol for in vitro modeling of specification and morphogenesis of early pancreas development using human pluripotent stem cell-based organoid differentiationChenglei Tian, Ulf Tiemann, Florian Hermann, et al.
Stem Cell Reports|December 30, 2015
Epigenetic Aberrations Are Not Specific to Transcription Factor-Mediated ReprogrammingUlf Tiemann, Guangming Wu, Adele Gabriele Marthaler, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|May 7, 2011
Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cellsUlf Tiemann, Malte Sgodda, Eva Warlich, et al.
Developmental Cell|March 8, 2025
Pancreatic alpha and beta cell fate choice is directed by apical-basal polarity dynamicsUlf Tiemann, Chenglei Tian, Florian Hermann, et al.
Scientific Reports|January 15, 2016
Enhanced OCT4 transcriptional activity substitutes for exogenous SOX2 in cellular reprogrammingAdele G Marthaler, Kenjiro Adachi, Ulf Tiemann, et al.
Stem Cell Reports|March 28, 2014
Counteracting activities of OCT4 and KLF4 during reprogramming to pluripotencyUlf Tiemann, Adele Gabriele Marthaler, Kenjiro Adachi, et al.
Scientific Reports|August 29, 2015
Dissecting the role of distinct OCT4-SOX2 heterodimer configurations in pluripotencyNatalia Tapia, Caitlin MacCarthy, Daniel Esch, et al.
Plos One|January 4, 2014
Reprogramming to pluripotency through a somatic stem cell intermediateAdele G Marthaler, Ulf Tiemann, Marcos J Araúzo-Bravo, et al.
Cell Stem Cell|December 23, 2022
An insulin hypersecretion phenotype precedes pancreatic β cell failure in MODY3 patient-specific cellsFlorian M Hermann, Maya Friis Kjærgaard, Chenglei Tian, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
STAR Protocols|May 22, 2025
Protocol for in vitro modeling of specification and morphogenesis of early pancreas development using human pluripotent stem cell-based organoid differentiationChenglei Tian, Ulf Tiemann, Florian Hermann, et al.
Stem Cell Reports|December 30, 2015
Epigenetic Aberrations Are Not Specific to Transcription Factor-Mediated ReprogrammingUlf Tiemann, Guangming Wu, Adele Gabriele Marthaler, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|May 7, 2011
Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cellsUlf Tiemann, Malte Sgodda, Eva Warlich, et al.
Developmental Cell|March 8, 2025
Pancreatic alpha and beta cell fate choice is directed by apical-basal polarity dynamicsUlf Tiemann, Chenglei Tian, Florian Hermann, et al.
Scientific Reports|January 15, 2016
Enhanced OCT4 transcriptional activity substitutes for exogenous SOX2 in cellular reprogrammingAdele G Marthaler, Kenjiro Adachi, Ulf Tiemann, et al.
Stem Cell Reports|March 28, 2014
Counteracting activities of OCT4 and KLF4 during reprogramming to pluripotencyUlf Tiemann, Adele Gabriele Marthaler, Kenjiro Adachi, et al.
Scientific Reports|August 29, 2015
Dissecting the role of distinct OCT4-SOX2 heterodimer configurations in pluripotencyNatalia Tapia, Caitlin MacCarthy, Daniel Esch, et al.
Plos One|January 4, 2014
Reprogramming to pluripotency through a somatic stem cell intermediateAdele G Marthaler, Ulf Tiemann, Marcos J Araúzo-Bravo, et al.
Cell Stem Cell|December 23, 2022
An insulin hypersecretion phenotype precedes pancreatic β cell failure in MODY3 patient-specific cellsFlorian M Hermann, Maya Friis Kjærgaard, Chenglei Tian, et al.
Pageof 1